Trilogy Capital’s DaVita DVA Stock Holding History

Trilogy Capital’s Portfolio DVA Stock Details DVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-17,058	Closed	-$878K	–	130
2018 Q4	$878K	Buy	17,058 +17,008	+34,016%	+$1.09M	0.12%	64
2018 Q3	$4K	Hold	50	–	–	﹤0.01%	422
2018 Q2	$3K	Hold	50	–	–	﹤0.01%	413
2018 Q1	$3K	Buy	+50	New	+$3.67K	﹤0.01%	345

Other funds holding DVA

Berkshire Hathaway Omaha, Nebraska $299B AUM 27.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

GCM

Gates Capital Management New York $4.16B AUM 21% 1-Year Est. Return

PCM

PAR Capital Management Boston, Massachusetts $4.03B AUM 35.05% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Trilogy Capital's DVA Position: Q1 2019 in Review

Trilogy Capital sold out of DaVita (DVA) in Q1 2019, closing a stake of 17,058 shares — an estimated $878K sold.

Trilogy Capital first reported a position in DVA in Q1 2018 and held it in 4 quarters. The position peaked at $878K in Q4 2018. 440 funds tracked by Wall St. Rank hold DVA as of Q1 2019.

Trilogy Capital reported no remaining DaVita position as of Q1 2019 after selling out during the quarter.
Trilogy Capital sold 17,058 DaVita shares in Q1 2019, an estimated $878K.
Trilogy Capital first reported a position in DaVita in Q1 2018 and held it in 4 quarters.
Trilogy Capital's DaVita position peaked at $878K in Q4 2018.
440 funds tracked by Wall St. Rank held DaVita as of Q1 2019.

Based on Trilogy Capital's 13F filing for Q1 2019, filed 17 Apr 2019.